Sharps Technology, Inc. (STSS)
NASDAQ: STSS · Real-Time Price · USD
1.960
-0.040 (-2.00%)
At close: May 13, 2026, 4:00 PM EDT
1.960
0.00 (0.00%)
After-hours: May 13, 2026, 7:29 PM EDT
Company Description
Sharps Technology, Inc. engages in the marketing and distribution of syringe products and related drug-delivery systems in the United States and internationally.
The company operates in two segments, Medical Device Packaging and Digital Asset Treasury. It distributes and markets safety syringes under the SecureGard, SoloGard, and Provensa brands; prefillable polymer syringes; and pharmaceutical services.
The company also engages in executing and managing its treasury platform, which focuses on accumulating Solana.
Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc.
| Country | United States |
| Founded | 2017 |
| IPO Date | Apr 14, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 55 |
| CEO | Paul Danner |
Contact Details
Address: 105 Maxess Road, Suite 124 Melville, New York 11747 United States | |
| Phone | 631 574 4436 |
| Website | sharpstechnology.com |
Stock Details
| Ticker Symbol | STSS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.25 |
| CIK Code | 1737995 |
| CUSIP Number | 82003F309 |
| ISIN Number | US82003F3091 |
| Employer ID | 82-3751728 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Paul Kruger Danner III | Executive Chairman and Principal Executive and Financial Officer |
| Yuwen Zhang | Chief Investment Officer and Director |
| Arthur R. Levine CPA | Interim Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 31, 2026 | 10-K | Annual Report |
| Feb 23, 2026 | 8-K | Current Report |
| Feb 13, 2026 | SCHEDULE 13D/A | Filing |
| Feb 13, 2026 | SCHEDULE 13D | Filing |
| Jan 30, 2026 | EFFECT | Notice of Effectiveness |
| Jan 26, 2026 | SCHEDULE 13G | Filing |
| Jan 23, 2026 | SCHEDULE 13G/A | Filing |
| Jan 16, 2026 | 8-K | Current Report |
| Jan 16, 2026 | 8-K | Current Report |
| Jan 15, 2026 | SCHEDULE 13G/A | Filing |